About Kanad Das
Form D filings for Actym Therapeutics from 2020 to 2023 list Kanad Das as director.
Kanad Das first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Kanad Das in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kanad Das works with at each company, as listed on that company's latest Form D.
Actym Therapeutics, Inc. · Form D, Jul 6, 2023
CT
Christopher Thanos
Chief Executive Officer and director
BC
Benjamin Chen
Director
RM
Ron Mazumder
Director
JC
Julie Cherrington
Director